RYMAX (RYMAX) Stock Price & Analysis
RYMAX (RYMAX) fell 2.40% to USD 74.35 as of June 10, 2026 at 19:38 UTC, according to Nexqual real-time market data.
RYMAX last closed at USD 76.18; the session ranged USD 74.35–74.35 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 46.58–82.66 (NAS). Source: Nexqual, June 10, 2026 at 19:38 UTC.
Key Statistics (as of June 10, 2026 at 19:38 UTC)
| Price | USD 74.35 |
|---|---|
| Change | ▼ 2.40% (down) |
| Previous Close | USD 76.18 |
| Open | USD 74.35 |
| Day Range | USD 74.35 – 74.35 |
| 52-Week Range | USD 46.58 – 82.66 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (RYMAX)
Nexqual's technical model rates RYMAX "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 19:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.33 (neutral) |
| vs SMA50 | Below (USD 75.26) |
| MACD | 0.55 (positive) |
Financial Health Score (RYMAX)
Nexqual rates RYMAX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 19:38 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTAX | Rydex Series Fds, Technology Fu | USD 285.26 | ▼ 2% |
| RYKAX | Rydex Series Fds, Banking Fund | USD 108.14 | ▲ 1.28% |
| RYHAX | Rydex Series Fds, Health Care F | USD 115.74 | ▲ 1.83% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 61.79 | ▲ 1.73% |
| RYCAX | Rydex Series Fds, Consumer Prod | USD 93.71 | ▲ 1.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 19:38 UTC. This page is informational and not investment advice.